GenoLogics, a developer of lab and scientific data management solutions, has completed a second round of financing led by OVP Venture Partners in Seattle, together with Growth Works and Yaletown Venture Partners. This round of financing will allow the company to accelerate its systems biology market penetration strategy.
This financing round dovetails with the introduction of GenoLogics' latest product, Geneus, which targets the lab and data management segment of the genomics market. These funds will enable GenoLogics to accelerate the development of Geneus and respond faster to the myriad of emerging genomics and systems biology opportunities that are surfacing.
Dr Rick LeFaivre, partner at OVP Venture Partners, commented: 'We firmly believe that GenoLogics has significant market opportunity and we are committed to helping the company become another success story.'